{"title":"绝经前和绝经后妇女代谢综合征的比较评价","authors":"A. Toppo, S. Varma, L. Sahu","doi":"10.9790/0853-1606140109","DOIUrl":null,"url":null,"abstract":"Background:The prevalence of the Metabolic Syndrome is increasing tremendously due to increase in obesity around the World. Metabolic Syndrome doubles the risk of Atherosclerotic Cardiovascular diseases and approximately four fold increases the risk of developing type II diabetes mellitus. It has been seen that Metabolic Syndrome is on the rising trend especially in post-menopausal women. Metabolic Syndrome is widely increasing especially in the transition phase in every woman’s life from premenopausal to menopausal phase. The aim of this study is to compare presence of metabolic syndrome and its components in premenopausal and post-menopausal women. Material and Methods: The study was conducted in 300 pre-menopausal and 300 postmenopausal women attending Medicine OPD and admitted in ward of Dr. B.R.A.M. Hospital, Raipur C.G. from March 2015 to August 2016.The objective of the study was explained and informed to women and data of each women was recorded in identical pre designed proforma after informed and written consent. Participants were categorized into two groups Pre-menopausal age group and Post-menopausal age group. Investigations including Fasting blood sugar, Lipid Profile and Anthropometric measurements including height, weight, waist circumference (WC) and hip circumference (HC) was recorded. A modified definition by the Adult Treatment Panel III guideline of the National Cholesterol Education Program was used to categorize the subjects according to presence of metabolic syndrome. Results: In the present study the mean age of pre-menopausal and postmenopausal group was 42.8 yrs and 54.5 yrs respectively in a study group of 300 women in each. The mean age of attaining menopause in present study was 46 ± 3.1 yrs. Mean systolic BP in pre-menopausal and post-menopausal study group was 117.13±10.87mmHg and 118.23+13.15mmHg respectively. Mean Diastolic BP in pre-menopausal and postmenopausal study group was 78.55 ± 8.19mmHg and 77.70+9.24mmHg respectively. No significant difference was observed between two groups regarding systolic BP (p=0.265) and diastolic BP. (p=0.234) The mean Waist Circumference (WC) was 78.96 ± 8.84 cms and 80.11±10.82 cms in pre and post menopausal group respectively with no significant difference. Waist Hip Ratio was found to be significantly higher in postmenopausal subjects compare to pre-menopausal subjects.(p=0.001). BMI was was found to be significantly higher in post-menopausal subjects as compared to pre-menopausal subjects.(p=0.003). TG was found to be significantly higher in Postmenopausal subjects compared to pre -menopausal subjects (p<0.0001). HDL was found to be significantly lower in Post-menopausal subjects compared to premenopausal subjects (p=0.071).FBS and PPBS were found to be significantly higher in Postmenopausal subjects as compared to pre-menopausal subjects. Raised FBS levels in post-menopausal subjects was statistically significant (p<0.0001) in the study. The overall prevalence of Metabolic Syndrome as per NCEP ATP III and IDF criteria was 38% and 50.7%. respectively in our study. The prevalence of Metabolic Syndrome in post-menopausal women as per NCEP ATP III and IDF criteria was 48.6% and 56.8% respectively. Prevalence of Metabolic Syndrome in pre-menopausal women as per NCEP ATP III criteria is 27.4%. and 44.6% as per IDF criteria. In pre-menopausal group – Among this study subjects 1.47% had five risk factors of Metabolic Syndrome, 15.3%had four, 10.43%had three, 45.9% had two risk factors while 26.9% had only one risk factor of Metabolic Syndrome. In post-menopausal group 10.2% had five risk factors of Metabolic Syndrome and 40.32%had four risk factors while 49.4%had three and50.9% had two and 36.9%had one risk factor of Metabolic Syndrome in the study. Conclusion: In present study there was high prevalence of Metabolic Syndrome (48.6%) among postmenopausal women than pre-menopausal women (27.4%) The incidence of Metabolic Syndrome increases with age , peak is seen in fourth to sixth decade. Dyslipidemia and abdominal obesity were the most prevalent components of Metabolic Syndrome among these women.","PeriodicalId":14489,"journal":{"name":"IOSR Journal of Dental and Medical Sciences","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Comparative Evaluation of Metabolic Syndrome in Premenopausal and Postmenopausal Women\",\"authors\":\"A. Toppo, S. Varma, L. Sahu\",\"doi\":\"10.9790/0853-1606140109\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background:The prevalence of the Metabolic Syndrome is increasing tremendously due to increase in obesity around the World. Metabolic Syndrome doubles the risk of Atherosclerotic Cardiovascular diseases and approximately four fold increases the risk of developing type II diabetes mellitus. It has been seen that Metabolic Syndrome is on the rising trend especially in post-menopausal women. Metabolic Syndrome is widely increasing especially in the transition phase in every woman’s life from premenopausal to menopausal phase. The aim of this study is to compare presence of metabolic syndrome and its components in premenopausal and post-menopausal women. Material and Methods: The study was conducted in 300 pre-menopausal and 300 postmenopausal women attending Medicine OPD and admitted in ward of Dr. B.R.A.M. Hospital, Raipur C.G. from March 2015 to August 2016.The objective of the study was explained and informed to women and data of each women was recorded in identical pre designed proforma after informed and written consent. Participants were categorized into two groups Pre-menopausal age group and Post-menopausal age group. Investigations including Fasting blood sugar, Lipid Profile and Anthropometric measurements including height, weight, waist circumference (WC) and hip circumference (HC) was recorded. A modified definition by the Adult Treatment Panel III guideline of the National Cholesterol Education Program was used to categorize the subjects according to presence of metabolic syndrome. Results: In the present study the mean age of pre-menopausal and postmenopausal group was 42.8 yrs and 54.5 yrs respectively in a study group of 300 women in each. The mean age of attaining menopause in present study was 46 ± 3.1 yrs. Mean systolic BP in pre-menopausal and post-menopausal study group was 117.13±10.87mmHg and 118.23+13.15mmHg respectively. Mean Diastolic BP in pre-menopausal and postmenopausal study group was 78.55 ± 8.19mmHg and 77.70+9.24mmHg respectively. No significant difference was observed between two groups regarding systolic BP (p=0.265) and diastolic BP. (p=0.234) The mean Waist Circumference (WC) was 78.96 ± 8.84 cms and 80.11±10.82 cms in pre and post menopausal group respectively with no significant difference. Waist Hip Ratio was found to be significantly higher in postmenopausal subjects compare to pre-menopausal subjects.(p=0.001). BMI was was found to be significantly higher in post-menopausal subjects as compared to pre-menopausal subjects.(p=0.003). TG was found to be significantly higher in Postmenopausal subjects compared to pre -menopausal subjects (p<0.0001). HDL was found to be significantly lower in Post-menopausal subjects compared to premenopausal subjects (p=0.071).FBS and PPBS were found to be significantly higher in Postmenopausal subjects as compared to pre-menopausal subjects. Raised FBS levels in post-menopausal subjects was statistically significant (p<0.0001) in the study. The overall prevalence of Metabolic Syndrome as per NCEP ATP III and IDF criteria was 38% and 50.7%. respectively in our study. The prevalence of Metabolic Syndrome in post-menopausal women as per NCEP ATP III and IDF criteria was 48.6% and 56.8% respectively. Prevalence of Metabolic Syndrome in pre-menopausal women as per NCEP ATP III criteria is 27.4%. and 44.6% as per IDF criteria. In pre-menopausal group – Among this study subjects 1.47% had five risk factors of Metabolic Syndrome, 15.3%had four, 10.43%had three, 45.9% had two risk factors while 26.9% had only one risk factor of Metabolic Syndrome. In post-menopausal group 10.2% had five risk factors of Metabolic Syndrome and 40.32%had four risk factors while 49.4%had three and50.9% had two and 36.9%had one risk factor of Metabolic Syndrome in the study. Conclusion: In present study there was high prevalence of Metabolic Syndrome (48.6%) among postmenopausal women than pre-menopausal women (27.4%) The incidence of Metabolic Syndrome increases with age , peak is seen in fourth to sixth decade. Dyslipidemia and abdominal obesity were the most prevalent components of Metabolic Syndrome among these women.\",\"PeriodicalId\":14489,\"journal\":{\"name\":\"IOSR Journal of Dental and Medical Sciences\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"IOSR Journal of Dental and Medical Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.9790/0853-1606140109\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"IOSR Journal of Dental and Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9790/0853-1606140109","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
摘要
背景:由于世界范围内肥胖的增加,代谢综合征的患病率正在急剧增加。代谢综合征使患动脉粥样硬化性心血管疾病的风险增加一倍,使患II型糖尿病的风险增加约四倍。已经看到代谢综合征呈上升趋势,特别是绝经后妇女。代谢综合征在每个妇女从绝经前到绝经期的过渡阶段普遍增加。本研究的目的是比较绝经前和绝经后妇女代谢综合征及其组成部分的存在。材料与方法:本研究于2015年3月至2016年8月在Raipur C.G. Dr. B.R.A.M.医院内科门诊就诊的300名绝经前和300名绝经后妇女中进行。向妇女解释和告知研究的目的,并在知情和书面同意后以相同的预先设计的形式记录每位妇女的数据。参与者被分为两组,绝经前年龄组和绝经后年龄组。调查包括空腹血糖、血脂和人体测量,包括身高、体重、腰围和臀围。根据国家胆固醇教育计划成人治疗小组III指南的修改定义,根据代谢综合征的存在对受试者进行分类。结果:在本研究中,绝经前组和绝经后组的平均年龄分别为42.8岁和54.5岁,每组300名妇女。绝经的平均年龄为46±3.1岁。绝经前和绝经后研究组的平均收缩压分别为117.13±10.87mmHg和118.23+13.15mmHg。绝经前和绝经后研究组的平均舒张压分别为78.55±8.19mmHg和77.70+9.24mmHg。两组之间收缩压(p=0.265)和舒张压无显著差异。绝经前组和绝经后组的平均腰围(WC)分别为78.96±8.84 cms和80.11±10.82 cms,差异无统计学意义(p=0.234)。绝经后受试者的腰臀比明显高于绝经前受试者(p=0.001)。发现绝经后受试者的BMI明显高于绝经前受试者(p=0.003)。发现绝经后受试者的TG明显高于绝经前受试者(p<0.0001)。与绝经前受试者相比,绝经后受试者的HDL显著降低(p=0.071)。发现绝经后受试者的FBS和PPBS明显高于绝经前受试者。绝经后受试者FBS水平升高有统计学意义(p<0.0001)。根据NCEP ATP III和IDF标准,代谢综合征的总患病率分别为38%和50.7%。分别在我们的学习。根据NCEP ATP III和IDF标准,绝经后妇女代谢综合征的患病率分别为48.6%和56.8%。根据NCEP ATP III标准,绝经前妇女代谢综合征的患病率为27.4%。按IDF标准44.6%。绝经前组-本研究对象中有1.47%有5种代谢综合征危险因素,15.3%有4种,10.43%有3种,45.9%有2种,26.9%只有一种代谢综合征危险因素。绝经后组有5种危险因素的占10.2%,有4种危险因素的占40.32%,有3种危险因素的占49.4%,有2种危险因素的占50.9%,有1种危险因素的占36.9%。结论:绝经后妇女代谢综合征患病率(48.6%)高于绝经前妇女(27.4%),随年龄增长代谢综合征发病率增高,在40 ~ 60岁达到高峰。在这些女性中,血脂异常和腹部肥胖是代谢综合征最普遍的组成部分。
Comparative Evaluation of Metabolic Syndrome in Premenopausal and Postmenopausal Women
Background:The prevalence of the Metabolic Syndrome is increasing tremendously due to increase in obesity around the World. Metabolic Syndrome doubles the risk of Atherosclerotic Cardiovascular diseases and approximately four fold increases the risk of developing type II diabetes mellitus. It has been seen that Metabolic Syndrome is on the rising trend especially in post-menopausal women. Metabolic Syndrome is widely increasing especially in the transition phase in every woman’s life from premenopausal to menopausal phase. The aim of this study is to compare presence of metabolic syndrome and its components in premenopausal and post-menopausal women. Material and Methods: The study was conducted in 300 pre-menopausal and 300 postmenopausal women attending Medicine OPD and admitted in ward of Dr. B.R.A.M. Hospital, Raipur C.G. from March 2015 to August 2016.The objective of the study was explained and informed to women and data of each women was recorded in identical pre designed proforma after informed and written consent. Participants were categorized into two groups Pre-menopausal age group and Post-menopausal age group. Investigations including Fasting blood sugar, Lipid Profile and Anthropometric measurements including height, weight, waist circumference (WC) and hip circumference (HC) was recorded. A modified definition by the Adult Treatment Panel III guideline of the National Cholesterol Education Program was used to categorize the subjects according to presence of metabolic syndrome. Results: In the present study the mean age of pre-menopausal and postmenopausal group was 42.8 yrs and 54.5 yrs respectively in a study group of 300 women in each. The mean age of attaining menopause in present study was 46 ± 3.1 yrs. Mean systolic BP in pre-menopausal and post-menopausal study group was 117.13±10.87mmHg and 118.23+13.15mmHg respectively. Mean Diastolic BP in pre-menopausal and postmenopausal study group was 78.55 ± 8.19mmHg and 77.70+9.24mmHg respectively. No significant difference was observed between two groups regarding systolic BP (p=0.265) and diastolic BP. (p=0.234) The mean Waist Circumference (WC) was 78.96 ± 8.84 cms and 80.11±10.82 cms in pre and post menopausal group respectively with no significant difference. Waist Hip Ratio was found to be significantly higher in postmenopausal subjects compare to pre-menopausal subjects.(p=0.001). BMI was was found to be significantly higher in post-menopausal subjects as compared to pre-menopausal subjects.(p=0.003). TG was found to be significantly higher in Postmenopausal subjects compared to pre -menopausal subjects (p<0.0001). HDL was found to be significantly lower in Post-menopausal subjects compared to premenopausal subjects (p=0.071).FBS and PPBS were found to be significantly higher in Postmenopausal subjects as compared to pre-menopausal subjects. Raised FBS levels in post-menopausal subjects was statistically significant (p<0.0001) in the study. The overall prevalence of Metabolic Syndrome as per NCEP ATP III and IDF criteria was 38% and 50.7%. respectively in our study. The prevalence of Metabolic Syndrome in post-menopausal women as per NCEP ATP III and IDF criteria was 48.6% and 56.8% respectively. Prevalence of Metabolic Syndrome in pre-menopausal women as per NCEP ATP III criteria is 27.4%. and 44.6% as per IDF criteria. In pre-menopausal group – Among this study subjects 1.47% had five risk factors of Metabolic Syndrome, 15.3%had four, 10.43%had three, 45.9% had two risk factors while 26.9% had only one risk factor of Metabolic Syndrome. In post-menopausal group 10.2% had five risk factors of Metabolic Syndrome and 40.32%had four risk factors while 49.4%had three and50.9% had two and 36.9%had one risk factor of Metabolic Syndrome in the study. Conclusion: In present study there was high prevalence of Metabolic Syndrome (48.6%) among postmenopausal women than pre-menopausal women (27.4%) The incidence of Metabolic Syndrome increases with age , peak is seen in fourth to sixth decade. Dyslipidemia and abdominal obesity were the most prevalent components of Metabolic Syndrome among these women.